LAUSR

Pharmaceutical and personal care products are frequently used in various fields and released into water bodies from the outlets of wastewater treatment plants. These products can harm the environment and human health even at low concentrations. Carbamazepine (CBZ), the most persistent pharmaceutical, has frequently been found in surface waters that bypassed the secondary treatments of conventional activated sludge. In addition, the treatment of phosphate in wastewater by the electrochemical process has recently attracted much attention because of its ability to remove, recover, and prevent environmental problems associated with eutrophication. This study proposes using the electrochemical process as an advanced oxidation process to simultaneously treat CBZ and phosphate from the moving-bed membrane bioreactor effluent. The study includes a long-term survey of CBZ treatment efficiency and common parameters of synthetic wastewater in the moving-bed membrane bioreactor system. Afterward, the electrochemical process is applied as an advanced oxidation process for the simultaneous removal of CBZ and phosphate from the moving-bed membrane bioreactor. Under the investigated conditions, CBZ has proven not to be an inhibitor of microbial activity, as evidenced by the high extent of chemical oxygen demand and nutrient removal. Using a factorial design, the electrochemical process using Pt/Ti as anode and cathode under optimal conditions (reaction time—80 min, bias potential—3 V, and electrode distance—1 cm) resulted in as high as 56.94% CBZ and 95.95% phosphate removal, respectively. The results demonstrated the ability to combine an electrochemical and a moving-bed membrane bioreactor process to simultaneously remove CBZ and phosphate in wastewater.